如何實踐AI在醫療臨床的應用：GenAI完美風暴、未來能力、資安風險、RCCP法規

2025-07-27 / 記者王柏豪

25日，BIOAsia-Taiwan亞洲生技大會論壇來到第三天。隨著AI人工智慧應用遍地開花，智慧醫療應用在健康照護與診斷正在重新定義全球醫療服務的模式，但也伴隨而來各種法規限制、數據來源、資安問題以及技術上的不確定性，Session9「智慧醫療」邀請到現任臺北醫學大學(TMU)董事長暨講座教授陳瑞杰、臺北醫學大學校長吳麥斯、鴻海研究院執行長李維斌、美商安美瑞台灣公司營運長何佳樺，並在臺北醫學大學...

MolecularDevices BIOAsia-Taiwan2025 GBIHighlights

FDA Modernization Act 3.0 is here—Can iPSC lead the future of animal-free drug testing?

2025-07-27 / GlobalBio & Investment

AtBIOAsia–Taiwan2025,LumiSTARBiotechnologyandMolecularDevices(HK)hostedacutting-edgeSatelliteSymposiumonNext-GenerationApproachesinDrugDevelopment,spotlightingiPSC-deriveddiseasemodels,high-thro...

2025BIOAsia-Taiwan 2025亞洲生技大會亞洲生技大會 ADC 雙特異性抗體抗體新藥

藥華藥、圓祥曝抗體研發策略 ADC、雙特異性抗體、AI仍是大勢所趨！

2025-07-27 / 記者吳培安

日前(24日)，BIOAsia-Taiwan亞洲生技大會論壇第二日之中，創新論壇7(SessionA-7)主題聚焦於抗體衍生藥物的創新開發與跨領域應用，邀請到藥華醫藥創新研究中心資深總監陳銘堂、圓祥生技執行長何正宏，分享各自的抗體藥物技術與開發最新進展，綜合討論也沿襲創新論壇A6主題，揭示藥物抗體複合體(ADC)、雙特異性抗體和AI應用，依然是抗體開發領域的當紅趨勢。大廠相繼投入次世代「免疫細胞...

GBIHighlights

PRIM Protein, Next-Gen ADCs & Brain-Targeting Nano Platform—3 Highlights You Can’t Miss

2025-07-27 / GlobalBio & Investment

AtBIOAsia–Taiwan’sDay2InnovationForumA-6,expertsfromABBiosciences,OBIPharma,andNanocarryTherapeuticsunveiledcutting-edgeantibodyinnovations:Dr.Yen-MingHsu,FounderofABBiosciences,introduced...

GBIHighlights

Taiwan Bio Therapeutics & Mayo Clinic Launch Phoenix Investment Plan

2025-07-27 / GlobalBio & Investment

Focus:CellManufacturing&RegulatoryTCellTherapiesDuringBIOAsia–Taiwan2025,TaiwanBioTherapeutics(6892.TWO)announcedthesigningofanewtermsheetwithMayoClinic,deepeningtheirpartnershipandofficiall...

GBIHighlights

Exploring the Next Generation of Therapies

2025-07-27 / GlobalBio & Investment

Atthishigh-impactsession,globalexpertsfromDelosCapital,A*STAR,KuderConsulting,andICONBiotechunpackedkeytrendsshapingthefuture:fromN-of-1personalizedmedicine,tomodularmRNAmanufacturing,andprecision-tar...

GBIHighlights

15 Biotech Trailblazers Honored at the Outstanding Biotechnology Industry Awards

2025-07-27 / GlobalBio & Investment

AtthevibrantopeningofBIOAsia–TaiwanExhibition2025,theprestigiousOutstandingBiotechnologyIndustryAwardsspotlighted15top-performingcompaniesfortheirinnovation,potential,andimpact!AwardHighlights:G...

GBIHighlights

AI x Genomics = The Future of Drug Development

2025-07-27 / GlobalBio & Investment

FourbiotechvisionariesfromEurope,America,andAsiagatheredtoexplorehowAIandgenomicsarerewritingtherulesofclinicaldesignanddruginnovation:ManuelSanz(Founder,ONCOMATRYX):IntroducedOMTX705,anADCturning&quo...

GBIHighlights

GLP-1 Discoverer Takes the Stage—Reveals the Untold Story Behind the Breakthrough Drug!

2025-07-27 / GlobalBio & Investment

The2025BIOAsia–Taiwanofficiallykicksoff! OnDay1,globalbiotechleaders—fromTangPrizelaureatestoICBAChairandAmgenVPs—sharedcutting-edgeinsightsonthefutureofbiotech.KeyHighlights:ICBACha...

GBIHighlights

Asia’s top biotech event brings global leaders together — and a bold new vision!

2025-07-27 / GlobalBio & Investment

JapaneseimpactinvestorGeorgeHaraopenedthesummitbychampioningPublicInterestCapitalism:“Thepurposeofbusinessisnotprofit—it’stocreatehappinessandcontributetosociety.”Harareceivedt...

亞洲生技大會 BIOAsia-Taiwan2025 北醫

北醫檢測、治療、照護三箭齊發 17項智慧醫療創新技術落地臨床

2025-07-26 / 記者李林璦

7月24～27日，臺北醫學大學於2025亞洲生技大展展出17項智慧醫療技術，聚焦「Ambulatory(檢測)、Acute(治療)、Advanced(照護)」三大核心，驗證將創新技術從臨床落地到市場、從預防到照護全面佈局。北醫指出，其重視臨床導向的創新，結合研發處與事業處共同推動的「創新創業研發雨林」策略，落實雙和醫院與生醫園區資源整合，建構永續生醫生態系。在智慧醫療領域，北醫展出器官晶片模擬...

CDMO 抗體 CMC

泰福、聖安、Aridis CDMO實戰分享慎選產能、技術、執行力避當First-in-Trouble

2025-07-26 / 記者彭梓涵

今(24)日，BIOAsia-Taiwan亞洲生技大會論壇，創新論壇SessionA-5聚焦生物藥製造委託開發與製造服務(CDMO)策略，邀請泰福生技執行長StephenLam、聖安生醫研發暨臨床開發副總何慧君、AridisPharmaceuticals執行長VuTruong、泰福生技商務長MarcGoemans，分享台美企業在選擇CDMO上的實務經驗與挑戰，後與會來賓也點出，近年生技公司傾向與C...